Healthcare -
Biotechnology - NASDAQ - US
$ 1.8
-2.7 %
$ 393 M
Market Cap
-8.18
P/E
AKBA - ACCOUNTS PAYABLE
Accounts Payable AKBA - Akebia Therapeutics, Inc.
14.6 M
LAST VALUE
-33.99%
2 YEAR CAGR
-19.31%
5 YEAR CAGR
35.26%
10 YEAR CAGR